Nasal Congestion: Causes, Treatments & When to See a Doctor

## Overview Nasal congestion — commonly called a "stuffy nose" or "blocked nose" — is the sensation of restricted airflow through one or both nasal passages. It results primarily from swelling (engorgement) of the nasal mucosal blood vessels and, to a lesser extent, from excess mucus production. Classified under ICD-10 code **R09.81**, nasal congestion is one of the most frequent symptoms encountered in primary care, affecting hundreds of millions of people worldwide each year. Allergic rhinitis alone affects an estimated 10–30 % of the global adult population, and the common cold — the single most frequent cause of acute nasal congestion — accounts for roughly 500 million episodes annually in the United States [1]. Surveys consistently rank "stuffy nose" among the most bothersome symptoms during upper-respiratory infections, and it is a leading reason people purchase over-the-counter (OTC) medications [2]. People search for information on nasal congestion because the symptom disrupts sleep, impairs concentration, reduces quality of life, and can persist for weeks when mismanaged. Understanding when congestion is self-limiting, when it signals something more serious, and how to treat it safely is essential. --- ## Common Causes Nasal congestion is not a disease itself but a symptom with many possible origins. The underlying mechanism almost always involves vasodilation and increased vascular permeability in the rich venous sinusoids of the nasal mucosa, leading to tissue swelling that narrows the airway [1]. ### 1. Viral Upper-Respiratory Infections (Common Cold) **Frequency:** Most common cause overall. **Pathophysiology:** Rhinoviruses (and, less often, coronaviruses, RSV, adenoviruses) infect nasal epithelial cells, triggering release of pro-inflammatory cytokines (IL-1, IL-6, IL-8) and bradykinin. This produces vasodilation, plasma extravasation, and glandular hypersecretion. Congestion typically peaks at days 2–3 and resolves within 7–10 days [2]. ### 2. Allergic Rhinitis **Frequency:** Affects 10–30 % of adults globally. **Pathophysiology:** IgE-mediated mast-cell degranulation in the nasal mucosa releases histamine, leukotrienes, and prostaglandins in response to inhaled allergens (pollen, dust mites, pet dander, mold). Early-phase congestion occurs within minutes; a late-phase response at 4–8 hours can sustain blockage for days if exposure continues [3]. ### 3. Non-Allergic (Vasomotor) Rhinitis **Frequency:** ~25 % of chronic rhinitis cases. **Pathophysiology:** Autonomic dysregulation causes exaggerated parasympathetic stimulation of nasal blood vessels and glands. Triggers include temperature changes, strong odors, humidity, spicy food, and emotional stress. No IgE involvement is detectable [7]. ### 4. Acute and Chronic Sinusitis **Pathophysiology:** Obstruction of the ostiomeatal complex (from viral swelling or allergy) traps mucus, creating a favorable environment for secondary bacterial infection (*Streptococcus pneumoniae*, *Haemophilus influenzae*, *Moraxella catarrhalis*). Mucosal inflammation and purulent secretions worsen congestion. Chronic rhinosinusitis (CRS) lasts ≥ 12 weeks and may involve nasal polyps [6]. ### 5. Rhinitis Medicamentosa (Rebound Congestion) **Pathophysiology:** Prolonged use (> 3–5 days) of topical α-adrenergic decongestant sprays (oxymetazoline, xylometazoline) causes tachyphylaxis and rebound vasodilation. The nasal mucosa becomes dependent on the drug to maintain patency [1]. ### 6. Structural Causes Deviated nasal septum, turbinate hypertrophy, adenoid enlargement (children), and nasal polyps can produce chronic unilateral or bilateral congestion. These are diagnosed by anterior rhinoscopy or nasal endoscopy. ### 7. Hormonal Rhinitis Pregnancy ("rhinitis of pregnancy") affects ~20 % of pregnant individuals, typically in the second and third trimesters, mediated by estrogen-induced mucosal vasodilation. Hypothyroidism can also cause nasal mucosal edema. ### 8. Drug-Induced Rhinitis Medications including NSAIDs (especially aspirin), ACE inhibitors, beta-blockers, oral contraceptives, and some antihypertensives may provoke or worsen nasal congestion through various mechanisms (COX-1 inhibition, bradykinin accumulation, or direct vascular effects) [7]. --- ## RED FLAGS Most cases of nasal congestion are benign and self-limiting. However, seek **immediate medical attention (ER / 911)** if congestion is accompanied by: - **Difficulty breathing or severe respiratory distress** not relieved by mouth breathing - **High fever (≥ 39.4 °C / 103 °F)** with facial pain and altered mental status — may suggest intracranial complication of sinusitis (e.g., meningitis, cavernous sinus thrombosis) - **Unilateral bloody or purulent nasal discharge** with facial numbness or cranial-nerve deficits — raises concern for nasal or sinus malignancy - **Periorbital swelling, eye pain, or visual changes** — may indicate orbital cellulitis or subperiosteal abscess, a surgical emergency - **Severe headache, neck stiffness, or photophobia** alongside sinus symptoms — concern for meningeal involvement - **Nasal congestion in a neonate (< 3 months)** causing feeding difficulty or cyanosis — neonates are obligate nasal breathers and may decompensate rapidly - **Recurrent epistaxis with unilateral obstruction** lasting > 3 weeks, especially in adults over 40 — warrants urgent evaluation to exclude nasopharyngeal carcinoma - **Recent head or facial trauma** with clear, watery nasal drainage — possible cerebrospinal fluid (CSF) rhinorrhea --- ## Self-Care at Home The following non-pharmacological measures have evidence supporting their use for symptom relief: ### Saline Nasal Irrigation Isotonic or hypertonic saline irrigation (using a neti pot, squeeze bottle, or bulb syringe) mechanically flushes mucus, allergens, and inflammatory mediators from the nasal cavity. A review published in *American Family Physician* found that regular saline irrigation improves symptoms and reduces medication use in both allergic and infectious rhinitis (PMID:19904896) [5]. Use distilled, sterile, or previously boiled water to avoid rare but serious infections (e.g., *Naegleria fowleri*). ### Humidification Maintaining indoor humidity at 40–60 % may help keep nasal mucosa moist and reduce the sensation of congestion. Cool-mist humidifiers are generally preferred over warm-mist models to reduce burn risk, especially around children. Clean humidifiers regularly to prevent mold growth. ### Steam Inhalation Inhaling steam (e.g., from a bowl of hot water, with a towel draped over the head) may temporarily relieve congestion by warming and moistening the nasal passages. Evidence of objective efficacy is limited, but subjective improvement is commonly reported [2]. Caution: risk of thermal burns, especially in children. ### Elevation of the Head During Sleep Elevating the head of the bed by 15–30° (using extra pillows or a wedge) helps gravity-assisted drainage and may reduce nocturnal congestion and improve sleep quality. ### Adequate Hydration Drinking plenty of fluids (water, broth, warm teas) helps thin nasal secretions, making them easier to clear. There is no high-quality evidence that fluid intake above normal needs provides additional benefit, but dehydration can thicken mucus. ### Allergen Avoidance For allergic rhinitis, reducing exposure to identified triggers is foundational. Practical steps include using allergen-proof mattress and pillow encasements, washing bedding weekly in hot water, using HEPA filters, keeping windows closed during high-pollen seasons, and showering after outdoor activity [3]. ### Nasal Strips External nasal-dilator strips (e.g., Breathe Right®) mechanically widen the nasal valve and may improve airflow modestly. They do not treat the underlying cause but can help with sleep comfort. --- ## OTC Medications That Help The table below summarizes the main OTC drug classes used for nasal congestion relief in adults. | Class | Example(s) | Typical Adult Dose | Mechanism | Key Notes / Contraindications | |---|---|---|---|---| | **Oral decongestant** | Pseudoephedrine (Sudafed®) | 60 mg every 4–6 h (max 240 mg/day) | α₁-adrenergic agonist → vasoconstriction of nasal vessels | Avoid in uncontrolled hypertension, severe CAD, MAO-inhibitor use, hyperthyroidism. Behind the pharmacy counter in the US (CMEA regulations). May cause insomnia, tachycardia, elevated BP [4]. | | **Oral decongestant** | Phenylephrine (many cold products) | 10 mg every 4 h (max 60 mg/day) | α₁-adrenergic agonist | FDA advisory committee (2023) found oral phenylephrine at standard doses to be no more effective than placebo; FDA subsequently proposed revoking its OTC monograph status. Patients should be informed of limited efficacy. | | **Topical decongestant spray** | Oxymetazoline (Afrin®) | 2–3 sprays per nostril every 12 h | Direct α-adrenergic agonist → rapid local vasoconstriction | **Limit use to ≤ 3 consecutive days** to avoid rhinitis medicamentosa (rebound congestion). Not recommended for chronic use [1]. | | **Topical decongestant spray** | Xylometazoline | 2–3 sprays per nostril every 8–12 h | Same as above | Same 3-day limit. | | **Intranasal corticosteroid** | Fluticasone propionate (Flonase®), triamcinolone (Nasacort®), budesonide (Rhinocort®) | 1–2 sprays per nostril once daily | Reduces mucosal inflammation by suppressing cytokines, prostaglandins, and leukotrienes | Most effective class for allergic rhinitis congestion [3]. Onset: 12 h; peak effect at 3–7 days. Generally well tolerated; may cause minor nosebleeds. Now available OTC in many countries. | | **Oral antihistamine (2nd generation)** | Cetirizine (Zyrtec®), loratadine (Claritin®), fexofenadine (Allegra®) | Cetirizine 10 mg/day; loratadine 10 mg/day; fexofenadine 180 mg/day | H₁-receptor blockade; reduces histamine-mediated sneezing, itching, rhinorrhea | Modest effect on congestion alone; more effective combined with a decongestant. Cetirizine may cause mild drowsiness. Fexofenadine is least sedating [3]. | | **Intranasal antihistamine** | Azelastine (Astelin®/Astepro®) | 1–2 sprays per nostril twice daily | Topical H₁-blockade + anti-inflammatory properties | Available OTC in some markets. Bitter taste is common. More effective for congestion than oral antihistamines. | | **Oral antihistamine + decongestant combo** | Cetirizine/pseudoephedrine (Zyrtec-D®), loratadine/pseudoephedrine (Claritin-D®) | Per package directions | Combined mechanism | Useful for allergic rhinitis with prominent congestion. Same decongestant contraindications apply. | | **Guaifenesin (expectorant)** | Mucinex® | 200–400 mg every 4 h (max 2400 mg/day) | Increases respiratory-tract secretion volume and reduces viscosity | May help if thick mucus contributes to the sensation of congestion. Evidence of benefit is modest. Ensure adequate fluid intake. | > **Important:** A Cochrane review (PMID:27748955) confirmed that single-dose oral or topical decongestants provide short-term relief of nasal congestion in the common cold, but evidence for repeated-dose efficacy beyond a few days is limited [4]. --- ## Prescription Options When OTC treatments are insufficient or congestion is chronic, a clinician (primary care physician, ENT specialist, or allergist) may prescribe the following: | Class | Example(s) | Typical Adult Dose | When Prescribed / Notes | |---|---|---|---| | **Intranasal corticosteroid (Rx strength)** | Mometasone furoate (Nasonex®), ciclesonide (Omnaris®) | 2 sprays per nostril once daily | Moderate-to-severe allergic rhinitis; chronic rhinosinusitis without polyps. Low systemic bioavailability. | | **Intranasal corticosteroid + antihistamine combo** | Fluticasone/azelastine (Dymista®) | 1 spray per nostril twice daily | Superior to either component alone for moderate-severe allergic rhinitis (PMID:25644617) [3]. | | **Leukotriene receptor antagonist** | Montelukast (Singulair®) | 10 mg once daily at bedtime | Allergic rhinitis (especially with comorbid asthma). FDA black-box warning (2020) regarding neuropsychiatric events — use only when benefits outweigh risks. | | **Intranasal anticholinergic** | Ipratropium bromide 0.03 % (Atrovent Nasal®) | 2 sprays per nostril 2–3 times daily | Primarily reduces rhinorrhea rather than congestion; useful for vasomotor rhinitis with watery drip. | | **Oral corticosteroid (short course)** | Prednisone | 20–40 mg/day for 5–7 days (taper per clinician) | Severe nasal polyps or marked inflammatory congestion unresponsive to topical therapy. Not for routine use [6]. | | **Biologic therapy** | Dupilumab (Dupixent®), omalizumab (Xolair®), mepolizumab (Nucala®) | Varies (subcutaneous injection) | Chronic rhinosinusitis with nasal polyps (CRSwNP) refractory to surgery and topical steroids. Prescribed by ENT or allergist. Dupilumab (anti-IL-4Rα) is FDA-approved for CRSwNP [6]. | | **Antibiotics** | Amoxicillin-clavulanate, doxycycline | Per guidelines (typically 5–10 days) | Acute bacterial rhinosinusitis (symptoms ≥ 10 days without improvement, or worsening after initial improvement). NOT indicated for viral congestion. Prescriber: primary care or ENT [6]. | | **Topical decongestant (supervised taper)** | Oxymetazoline + fluticasone taper | Short course under medical supervision | Used to break rhinitis medicamentosa cycle: topical corticosteroid initiated simultaneously while decongestant is tapered over 1–2 weeks. | --- ## Lab Tests Typically Ordered Nasal congestion is usually diagnosed clinically. However, the following tests may be ordered when the cause is unclear or complications are suspected: | Test | Rationale | Link | |---|---|---| | **Nasal endoscopy** | Direct visualization of nasal cavity and ostiomeatal complex; identifies polyps, tumors, structural abnormalities, or purulent drainage | — | | **CT scan of sinuses** (non-contrast) | Gold standard imaging for chronic rhinosinusitis; assesses mucosal thickening, air-fluid levels, polyps, anatomic variants | — | | **Skin-prick allergy testing** | Identifies specific IgE-mediated allergen sensitivities in suspected allergic rhinitis | [/tests/skin-prick-allergy-test](/tests/skin-prick-allergy-test) | | **Serum-specific IgE (ImmunoCAP®)** | Alternative to skin-prick testing; useful when skin testing is impractical (e.g., widespread dermatitis, antihistamine use) | [/tests/specific-ige-blood-test](/tests/specific-ige-blood-test) | | **Complete blood count (CBC) with differential** | Elevated eosinophils may support allergic or eosinophilic etiology | [/tests/complete-blood-count](/tests/complete-blood-count) | | **Nasal cytology / smear** | Identifies predominant cell type (eosinophils vs. neutrophils) to differentiate allergic from infectious causes | — | | **Nasal inspiratory peak flow (NIPF)** | Objective measure of nasal airway patency; used in research and some specialty clinics to monitor treatment response | — | | **Biopsy** | Indicated only when malignancy, granulomatous disease (e.g., granulomatosis with polyangiitis), or other unusual pathology is suspected | — | --- ## Special Populations ### Children - Children experience 6–8 colds per year on average, each lasting 7–14 days, making nasal congestion extremely common in pediatrics [2]. - **Saline drops/spray and nasal suctioning** (bulb syringe) are first-line for infants and young children. - **OTC oral decongestants and cough-and-cold products are NOT recommended for children under 6 years** (FDA, AAP guidance). Several countries advise against their use under age 12 due to lack of efficacy data and risk of adverse events. - **Intranasal corticosteroids** (e.g., fluticasone, mometasone) are approved for allergic rhinitis in children ≥ 2 years; dosing should follow product labeling and pediatrician guidance. Long-term growth monitoring is advised. - **Antihistamines**: Cetirizine is approved from 6 months; loratadine from 2 years. Always verify age-appropriate dosing on the product label or with a pediatric pharmacist. **Do not extrapolate adult doses.** - **Neonates** (< 3 months) are obligate nasal breathers; any significant nasal obstruction may compromise feeding and oxygenation. Seek prompt medical evaluation. ### Pregnancy - Rhinitis of pregnancy occurs in approximately 20 % of pregnancies and can persist throughout gestation. - **Saline irrigation** is considered first-line and is safe throughout pregnancy. - **Intranasal corticosteroids**: Budesonide is generally preferred (former FDA Pregnancy Category B; most human safety data available). Other intranasal corticosteroids are used if budesonide is inadequate, with clinician guidance. - **Pseudoephedrine**: Generally avoided, especially in the first trimester, due to a small association with gastroschisis in some epidemiological studies. Use only if clearly needed and directed by an obstetrician. - **Oxymetazoline spray**: Limited systemic absorption; may be considered for short-term use (≤ 3 days) when benefits outweigh risks, per clinician advice. - **Oral antihistamines**: Cetirizine and loratadine are generally considered acceptable in pregnancy when needed, but should be used at the lowest effective dose and duration. - **Always consult an obstetrician or midwife** before starting any medication during pregnancy or while breastfeeding. ### Elderly - Age-related mucosal atrophy and reduced mucociliary clearance can predispose older adults to chronic congestion. - **Oral decongestants (pseudoephedrine, phenylephrine)** should be used with particular caution in the elderly due to higher prevalence of hypertension, coronary artery disease, prostatic hypertrophy (urinary retention risk), and potential drug interactions (e.g., MAO inhibitors, tricyclic antidepressants). The Beers Criteria list pseudoephedrine as potentially inappropriate in older adults. - **Intranasal corticosteroids** are generally well tolerated and are preferred for chronic allergic congestion in this age group. - Anticholinergic effects of first-generation antihistamines (diphenhydramine, chlorpheniramine) pose fall risk, cognitive impairment, and urinary retention — second-generation agents are strongly preferred. ### Athletes - Nasal congestion is common in athletes (exercise-induced rhinitis affects up to 40 % of competitive athletes, particularly in cold, dry, or chlorinated environments). - **Pseudoephedrine** is a World Anti-Doping Agency (WADA) monitored substance. Although no longer on the prohibited list at typical therapeutic doses (since 2004), urinary concentrations > 150 µg/mL at competition may trigger further investigation. Athletes subject to testing should document use and consult team physicians. - **Intranasal corticosteroids** are permitted by WADA without a Therapeutic Use Exemption (TUE). - **Oral corticosteroids** are prohibited in-competition by WADA and require a TUE. - Non-pharmacological measures (saline irrigation, nasal strips, pre-exercise warm-up to harness the nasal cycle) are preferred first-line strategies for athletes. --- ## When to Escalate Use the following decision thresholds to determine the appropriate level of care: ### Self-Care Is Appropriate When: - Congestion is mild to moderate, bilateral, and associated with typical cold symptoms (rhinorrhea, sneezing, mild sore throat) - Duration is < 10 days with gradual improvement - No fever, or only low-grade fever (< 38.3 °C / 101 °F) - The individual is otherwise healthy and not in a high-risk group ### See a GP / Primary Care (Within a Few Days) When: - Congestion persists **> 10 days without improvement** - Symptoms initially improve then **worsen again** ("double sickening") — suggests secondary bacterial sinusitis [6] - Moderate facial pain/pressure, tooth pain, or persistent purulent discharge - Recurrent episodes (≥ 4 per year) suggesting allergic or structural cause needing workup - Congestion is chronic (> 12 weeks) despite OTC treatment - Suspected medication-related cause (e.g., rhinitis medicamentosa or drug-induced rhinitis) ### Seek Urgent Care / Same-Day Appointment When: - **Fever ≥ 39 °C (102.2 °F)** with facial pain lasting > 3 days - **Unilateral symptoms** with bloody or foul-smelling discharge - Significant **periorbital edema** or erythema - Symptoms failing to respond to a completed course of first-line antibiotics ### Go to the ER / Call 911 When: - Signs of **orbital complication**: proptosis, restricted eye movement, double vision, vision loss - Signs of **intracranial complication**: severe headache, neck stiffness, altered consciousness, seizures - **Respiratory distress** in an infant unable to feed or maintain oxygenation - Suspected **CSF leak** (clear, watery, unilateral nasal drainage after head trauma) --- ## References [1] Naclerio RM, Bachert C, Baraniuk JN. Pathophysiology of nasal congestion. *Int J Gen Med*. 2010;3:47-57. PMID:20463825. [2] Eccles R. Understanding the symptoms of the common cold and influenza. *Lancet Infect Dis*. 2005;5(11):718-725. PMID:16253889. [3] Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: Allergic rhinitis. *Otolaryngol Head Neck Surg*. 2015;152(1 Suppl):S1-S43. PMID:25644617. [4] Deckx L, De Sutter AI, Guo L, Mir NA, van Driel ML. Nasal decongestants in monotherapy for the common cold. *Cochrane Database Syst Rev*. 2016;10(10):CD009612. PMID:27748955. [5] Rabago D, Zgierska A. Saline nasal irrigation for upper respiratory conditions. *Am Fam Physician*. 2009;80(10):1117-1119. PMID:19904896. [6] Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS 2020). *Rhinology*. 2020;58(Suppl S29):1-464. PMID:32077450. [7] Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. *J Allergy Clin Immunol*. 2008;122(2 Suppl):S1-S84. PMID:18662584. --- *Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment of medical conditions.*